New advances in matching and donor selection for HCT

26.9K
views
71
authors
6
articles
Cover image for research topic "New advances in matching and donor selection for HCT"
Editors
4
Impact
Loading...
12,541 views
20 citations

Class I Human Leukocyte Antigen (HLA) evolutionary divergence (HED) is a metric which reflects immunopeptidome diversity and has been associated with immune checkpoint inhibitor responses in solid tumors. Its impact and interest in allogeneic hematopoietic stem cell transplantation (HCT) have not yet been thoroughly studied. This study analyzed the clinical and immune impact of class I and II HED in 492 acute myeloid leukemia (AML) recipients undergoing HCT. The overall cohort was divided into a training (n=338) and a testing (n=132) set. Univariate cox screening found a positive impact of a high class I HED and a negative impact of a high class II HED on both disease-free (DFS) and overall survival (OS). These results were combined in a unique marker, class I/class II HED ratio, and assessed in the testing cohort. The final multivariate cox model confirmed the positive impact of a high versus low class I/class II HED ratio on both DFS (Hazard Ratio (HR) 0.41 [95% CI 0.2-0.83]; p=0.01) and OS (HR 0.34 [0.19-0.59]; p<0.001), independently of HLA matching and other HCT parameters. No significant association was found between the ratio and graft-versus-host disease (GvHD) nor with neutrophil and platelet recovery. A high class I HED was associated with a tendency for an increase in NK, CD8 T-cell, and B cell recovery at 12 months. These results introduce HED as an original and independent prognosis marker reflecting immunopeptidome diversity and alloreactivity after HCT.

4,768 views
18 citations
Open for submission
Frontiers Logo

Frontiers in Immunology

PTCY and Allo-HCT: A Deep Dive into Outcomes, Toxicities, and Patient-Centered Care
Edited by Maria Queralt Salas, Fotios V. Michelis, Carmen Martinez
Deadline
17 June 2025
Submit a paper
Recommended Research Topics
Frontiers Logo

Frontiers in Immunology

Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
Edited by Dominik Schneidawind, Everett Meyer
90.7K
views
90
authors
12
articles
Frontiers Logo

Frontiers in Immunology

The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
Edited by Antonella Mancusi, Antonio Pierini, Christopher G Kanakry
95K
views
37
authors
11
articles
Frontiers Logo

Frontiers in Immunology

Beyond Histocompatibility – Understanding the Non-MHC Determinants Shaping Transplantation Outcome and Tolerance Induction
Edited by Heth Roderick Turnquist, Xunrong Luo, Craig Alan Byersdorfer, Elizabeth Stenger
70.2K
views
66
authors
13
articles
Frontiers Logo

Frontiers in Immunology

Community Series in Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation: Volume II
Edited by Everett Meyer, Dominik Schneidawind
5.9K
views
29
authors
3
articles